Japanese Catheter Ablation Registry
Launched by NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER, JAPAN · Nov 1, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Japanese Catheter Ablation Registry is a nationwide study aimed at understanding how catheter ablation—a procedure used to treat irregular heartbeats (or arrhythmias)—is being performed across Japan. This registry is being conducted by the Japanese Heart Rhythm Society in partnership with the National Cerebral and Cardiovascular Center. The main goal is to gather information about the treatment methods, the types of procedures being done, and the facilities available for patients with arrhythmias in Japan.
If you or a loved one has undergone catheter ablation in Japan, you may be eligible to participate in this registry. The study is open to all patients who have received this treatment, as long as they agree to take part. Participants can expect to help researchers learn more about this important treatment, which may ultimately improve care for future patients. It’s important to note that the registry is voluntary, meaning you can choose whether or not to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients treated with catheter ablation in Japan
- Exclusion Criteria:
- • Patients who refused to consent
About National Cerebral And Cardiovascular Center, Japan
The National Cerebral and Cardiovascular Center (NCVC) in Japan is a leading research institution dedicated to advancing the understanding and treatment of cerebrovascular and cardiovascular diseases. Established to enhance clinical care through innovative research, the NCVC focuses on developing new therapeutic strategies, conducting cutting-edge clinical trials, and fostering collaboration among healthcare professionals. With a commitment to improving patient outcomes, the center leverages its state-of-the-art facilities and expertise to contribute significantly to the global medical community and public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suita, Osaka, Japan
Patients applied
Trial Officials
Teiichi Yamane, MD, PhD
Principal Investigator
The Jikei University School of Medicine
Kengo Kusano, MD, PhD
Principal Investigator
National Cerebral and Cardiovascular Center, Japan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials